Kyung-Nam Koh Selected Research

Stem Cell Transplantation

1/2023	High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma.
10/2021	Physeal Abnormalities in Children With High-risk Neuroblastoma Intensively Treated With/Without 13-Cis-Retinoic Acid.
1/2020	Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with 131 I-MIBG therapy for high-risk neuroblastoma.
6/2015	Successful use of brentuximab vedotin for refractory anaplastic large cell lymphoma as a bridging therapy to haploidentical stem cell transplantation and maintenance therapy post-transplantation.
4/2012	Haploidentical haematopoietic stem cell transplantation using CD3 or CD3/CD19 depletion and conditioning with fludarabine, cyclophosphamide and antithymocyte globulin for acquired severe aplastic anaemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyung-Nam Koh Research Topics

Disease

11	Neoplasms (Cancer) 01/2024 - 08/2016
6	Neuroblastoma 01/2024 - 04/2017
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2015
4	Infections 01/2023 - 03/2015
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 09/2015
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 04/2021 - 12/2010
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2019 - 04/2012
2	Lymphoma (Lymphomas) 06/2023 - 01/2020
2	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 01/2016
2	Sepsis (Septicemia) 11/2021 - 01/2021
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 08/2016
2	Leukemia 10/2019 - 03/2015
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 03/2015
1	Chronic Renal Insufficiency 01/2024
1	Ileus 01/2024
1	B-Cell Leukemia (Leukemia, B Cell) 06/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2022
1	Burkitt Lymphoma (Burkitt's Lymphoma) 03/2022
1	Germinoma 01/2022
1	Brain Neoplasms (Brain Tumor) 10/2021
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Hepatoblastoma 01/2021
1	Mevalonate Kinase Deficiency 01/2021
1	Cytomegalovirus Infections (Inclusion Disease) 01/2021
1	Hypothyroidism 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cardiotoxicity 01/2019
1	Obesity 05/2018
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 08/2016
1	Cerebral Hemorrhage 09/2015
1	Philadelphia Chromosome 09/2015
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 06/2015
1	Hemoglobinopathies 09/2013
1	beta-Thalassemia (Cooley's Anemia) 09/2013
1	Disease Progression 12/2012
1	Neurologic Manifestations (Neurological Manifestations) 12/2012
1	Central Nervous System Diseases (CNS Diseases) 12/2012

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint ProteinsIBA 01/2023 - 10/2019
2	LigandsIBA 01/2023 - 10/2019
2	EnzymesIBA 01/2023 - 01/2021
2	fludarabineIBA 06/2022 - 04/2012
2	3-Iodobenzylguanidine (Iobenguane)IBA 01/2020 - 04/2017
2	Proteins (Proteins, Gene)FDA Link 10/2019 - 12/2010
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2015 - 04/2012
1	Growth Hormone (Somatotropin)IBA 01/2024
1	Chimeric Antigen ReceptorsIBA 06/2023
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2023
1	AntigensIBA 01/2023
1	Busulfan (Busulfex)FDA Link 06/2022
1	Rituximab (Mabthera)FDA Link 03/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021
1	Isotretinoin (Accutane)FDA LinkGeneric 10/2021
1	Clofarabine (Clolar)FDA Link 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Mevalonic Acid (Mevalonate)IBA 01/2021
1	Foscarnet FDA LinkGeneric 01/2021
1	2-mercaptopurineIBA 01/2021
1	Formaldehyde (Formol)FDA Link 12/2020
1	ParaffinIBA 12/2020
1	pembrolizumabIBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019
1	B7-H1 AntigenIBA 10/2019
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 10/2019
1	Zoledronic Acid (Zometa)FDA Link 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	AnthracyclinesIBA 01/2019
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2019
1	Hormones (Hormone)IBA 05/2018
1	Chalcone (Benzalacetophenone)IBA 01/2018
1	flavokawain BIBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2016
1	Gemcitabine FDA Link 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 09/2015
1	Brentuximab VedotinIBA 06/2015
1	Monoclonal AntibodiesIBA 06/2015
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2015
1	Hemoglobins (Hemoglobin)IBA 09/2013
1	GlobinsIBA 09/2013
1	Matrix Metalloproteinase 12IBA 12/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2012

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 01/2023 - 12/2012
9	Therapeutics 04/2021 - 01/2015
8	Hematopoietic Stem Cell Transplantation 09/2023 - 06/2015
5	Stem Cell Transplantation 01/2023 - 04/2012
5	Transplantation 01/2021 - 03/2015
4	Cell Transplantation 06/2022 - 01/2018
2	Radiotherapy 01/2024 - 01/2020
2	Combined Modality Therapy 01/2024 - 10/2021
2	Haploidentical Transplantation 01/2020 - 01/2019
2	Induction Chemotherapy 01/2020 - 09/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2023
1	MACHO protocol 03/2022
1	Mechanical Ventilators (Ventilator) 11/2021
1	Adjuvant Radiotherapy 04/2021
1	Liver Transplantation 01/2021
1	Aftercare (After-Treatment) 10/2018